Tetratricopeptide Repeat Domain 12 (TTC12) Peptide
TTC12
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits TTC12
- TTC12 (Tetratricopeptide Repeat Domain 12 (TTC12))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-TTC12 antibody (Catalog #: ARP53725_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- TTC12 (Tetratricopeptide Repeat Domain 12 (TTC12))
- Synonymes
- TPARM Peptide, E330017O07Rik Peptide, tetratricopeptide repeat domain 12 Peptide, TTC12 Peptide, Ttc12 Peptide
- Sujet
-
TTC12 contains 3 TPR repeats. Hypermethylation of TTC12 gene may play a role in acute lymphoblastic leukemia. Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence.
Alias Symbols: FLJ13859, FLJ20535, TPARM
Protein Size: 732 - Poids moléculaire
- 81 kDa
- ID gène
- 54970
- NCBI Accession
- NM_017868, NP_060338
- UniProt
- B0YJB4
-
Vous êtes ici:
